Archive for 2013:
November 26th, 2013FDA lifts some safety restrictions on GlaxoSmithKline’s Avandia
FDA lifts some safety restrictions on GlaxoSmithKline's Avandia November 25th, 2013 The FDA announced Monday that it is overturning certain restrictions imposed on the use of GlaxoSmithKline's Avandia (rosiglitazone), citing trial data showing no elevated risk of heart attack or death in patients treated with the diabetes drug, versus standard […]
October 25th, 2013
The FDA Makes Ancient Remedies Unaffordable
The FDA Makes Ancient Remedies Unaffordable Oct. 24, 2013 This article, written by senior resident fellow at the Ludwig von Mises Institute Mark Thornton, was originally published by Mises on Oct. 24. I recently experienced severe pain in my feet, particularly in the big toes. In my imagination it felt […]
October 2nd, 2013
Can’t help it, I TOLD YOU SO !!!
STATINS DO CAUSE DEMENTIA...... Long-term statin use reduces dementia risk by 30%, researchers discover Statins, which are commonly used to treat high cholesterol, do not cause cognition problems in the short term and may offer significant protection against dementia in the long term. This is according to new research that […]
June 5th, 2013
FDA Gives Avandia Another Look
FDA Gives Avandia Another Look MedPage Today Published: June 03, 2013 This is another "I TOLD YOU SO" as I have always said chemically it is probably the best oral antidiabetic drugs made for the older patient and did not have the risks wrongly placed on the drug. A reassessment […]
April 22nd, 2013
Bone Drug Lowers Levels of Bone Growth Markers
Bone Drug Lowers Levels of Bone Growth Markers Published: April 18, 2013 Action Points *Note that this randomized trial demonstrated that treatment with zoledronic acid increased sclerostin, which may inhibit healthy bone turn-over. 8Be aware that no clinical outcomes (such as fracture) were studied in this trial. A drug used […]
Health care alerts
Video
